Legis Daily

To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to provide the Attorney General certain notifications in certain determinations made by the Secretary of improper prescribing of controlled substances, and for other purposes.

USA115th CongressHR-7369| House 
| Updated: 12/20/2018
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (1)
Raul Ruiz (Democratic)

Ways and Means Committee, Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
DEA Notification Act of 2018 This bill requires the Centers for Medicare & Medicaid Services to notify the Drug Enforcement Administration (DEA) of providers or suppliers that are prohibited from participating in Medicare due to improper prescriptions of controlled substances, and to recommend that the DEA consider revoking certain controlled substance registrations or waivers held by such providers or suppliers.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 20, 2018
Introduced in House
Dec 20, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • December 20, 2018
    Introduced in House
  • December 20, 2018
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Health

Drug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesHealth care qualityHealth facilities and institutionsLicensing and registrationsMedicarePrescription drugs

To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to provide the Attorney General certain notifications in certain determinations made by the Secretary of improper prescribing of controlled substances, and for other purposes.

USA115th CongressHR-7369| House 
| Updated: 12/20/2018
DEA Notification Act of 2018 This bill requires the Centers for Medicare & Medicaid Services to notify the Drug Enforcement Administration (DEA) of providers or suppliers that are prohibited from participating in Medicare due to improper prescriptions of controlled substances, and to recommend that the DEA consider revoking certain controlled substance registrations or waivers held by such providers or suppliers.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 20, 2018
Introduced in House
Dec 20, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • December 20, 2018
    Introduced in House
  • December 20, 2018
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (1)
Raul Ruiz (Democratic)

Ways and Means Committee, Judiciary Committee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesHealth care qualityHealth facilities and institutionsLicensing and registrationsMedicarePrescription drugs